Related Experiment Video
Updated: Jan 11, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Antiretroviral therapy-induced liver alterations
1Department of Rheumatology and Clinical Immunology, Freiburg University Hospital, D-79106 Freiburg, Germany. ulrich.walker@klinikum.uni-freiburg.de
Antiretroviral drugs can cause liver damage (hepatotoxicity) in HIV patients, leading to hospitalizations. Understanding risk factors and mechanisms is crucial for managing this prevalent side effect.
Area of Science:
- Hepatology
- Infectious Diseases
- Pharmacology
Background:
- Hepatotoxicity is a significant concern in HIV-infected individuals.
- Liver damage is a leading cause of hospitalization among this population.
Purpose of the Study:
- To review the prevalence, contributing factors, and mechanisms of antiretroviral drug-induced hepatotoxicity.
- To update knowledge on liver toxicity associated with various antiretroviral drug classes.
Main Methods:
- Literature review of studies on antiretroviral drug hepatotoxicity.
- Analysis of prevalence data and identified risk factors.
- Examination of proposed mechanisms of liver injury.
Main Results:
- Hepatotoxicity is highly prevalent in HIV patients, with liver steatosis observed in both coinfected and noncoinfected individuals.
- Specific drugs like nevirapine and certain nucleoside analogues show strong associations with severe liver toxicity and mitochondrial damage.
- Mechanisms include mitochondrial toxicity, UDP-glucuronosyltransferase inhibition by atazanavir, and potential cytokine imbalance from CCR5 inhibitors.
Conclusions:
- All classes of antiretroviral agents are associated with hepatotoxicity.
- Antiretroviral drug-induced liver injury remains a significant clinical problem contributing to hospitalizations in HIV patients.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Retrovirus Life Cycles
Hepatic Drug Excretion: Influencing Factors

